Atlas Venture Associates Ix, L.p. - Net Worth and Insider Trading

Atlas Venture Associates Ix, L.p. Net Worth

The estimated net worth of Atlas Venture Associates Ix, L.p. is at least $62 Million dollars as of 2024-11-10. Atlas Venture Associates Ix, L.p. is the 10% Owner of Intellia Therapeutics Inc and owns about 3,729,788 shares of Intellia Therapeutics Inc (NTLA) stock worth over $62 Million. Details can be seen in Atlas Venture Associates Ix, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Atlas Venture Associates Ix, L.p. has not made any transactions after 2017-03-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Atlas Venture Associates Ix, L.p.

To

Atlas Venture Associates Ix, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Associates Ix, L.p. owns 4 companies in total, including Surface Oncology Inc (SURF) , Cogent Biosciences Inc (COGT) , and Spero Therapeutics Inc (SPRO) among others .

Click here to see the complete history of Atlas Venture Associates Ix, L.p.’s form 4 insider trades.

Insider Ownership Summary of Atlas Venture Associates Ix, L.p.

Ticker Comapny Transaction Date Type of Owner
SURF Surface Oncology Inc 2020-12-17 10 percent owner
COGT Cogent Biosciences Inc 2018-03-28 10 percent owner
SPRO Spero Therapeutics Inc 2017-11-01 10 percent owner
LIMIT LIMIT 2017-07-07 10 percent owner

Atlas Venture Associates Ix, L.p. Latest Holdings Summary

Atlas Venture Associates Ix, L.p. currently owns a total of 1 stock. Atlas Venture Associates Ix, L.p. owns 3,729,788 shares of Intellia Therapeutics Inc (NTLA) as of March 10, 2017, with a value of $62 Million.

Latest Holdings of Atlas Venture Associates Ix, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NTLA Intellia Therapeutics Inc 2017-03-10 3,729,788 16.73 62,399,353

Holding Weightings of Atlas Venture Associates Ix, L.p.


Atlas Venture Associates Ix, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Atlas Venture Associates Ix, L.p. has made a total of 0 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years. The most-recent trade in Intellia Therapeutics Inc is the sale of 21,132 shares on March 10, 2017, which brought Atlas Venture Associates Ix, L.p. around $293,946.

Insider Trading History of Atlas Venture Associates Ix, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Atlas Venture Associates Ix, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Atlas Venture Associates Ix, L.p. Ownership Network

Ownership Network List of Atlas Venture Associates Ix, L.p.

No Data

Ownership Network Relation of Atlas Venture Associates Ix, L.p.

Insider Network Chart

Atlas Venture Associates Ix, L.p. Owned Company Details

What does Surface Oncology Inc do?

Who are the key executives at Surface Oncology Inc?

Atlas Venture Associates Ix, L.p. is the 10 percent owner of Surface Oncology Inc. Other key executives at Surface Oncology Inc include Deputy GC Chandra Adams , Chief Medical Officer Alison Oneill , and See Remarks Jessica Fees .

Surface Oncology Inc (SURF) Insider Trades Summary

Over the past 18 months, Atlas Venture Associates Ix, L.p. made no insider transaction in Surface Oncology Inc (SURF). Other recent insider transactions involving Surface Oncology Inc (SURF) include a net sale of 16,713 shares made by Robert W. Ross , a net sale of 9,434 shares made by Jessica Fees , and a net sale of 7,042 shares made by Alison Oneill .

In summary, during the past 3 months, insiders sold 0 shares of Surface Oncology Inc (SURF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,090 shares of Surface Oncology Inc (SURF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,090 shares.

Surface Oncology Inc (SURF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Surface Oncology Inc Insider Transactions

No Available Data

Atlas Venture Associates Ix, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Atlas Venture Associates Ix, L.p.. You might contact Atlas Venture Associates Ix, L.p. via mailing address: 46 Wareham Street, Floor 3, Boston Ma 02118.